BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19525447)

  • 41. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
    Ito K; Yokoyama J; Kubota K; Morooka M; Shiibashi M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1318-27. PubMed ID: 20306040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative parameters derived from
    Meng Z; Zhang L; Huang C; Piao Y; Chen X; Xian J
    Neuroradiology; 2022 Nov; 64(11):2153-2162. PubMed ID: 36121469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy.
    Min M; Lee MT; Lin P; Holloway L; Wijesekera Dj; Gooneratne D; Rai R; Xuan W; Fowler A; Forstner D; Liney G
    Br J Radiol; 2016; 89(1058):20150530. PubMed ID: 26648404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
    Yao M; Luo P; Hoffman HT; Chang K; Graham MM; Menda Y; Tan H; Buatti JM
    Am J Clin Oncol; 2007 Jun; 30(3):264-70. PubMed ID: 17551303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.
    Vandecaveye V; De Keyzer F; Nuyts S; Deraedt K; Dirix P; Hamaekers P; Vander Poorten V; Delaere P; Hermans R
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):960-71. PubMed ID: 17141979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
    Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
    Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.
    Mönnich D; Thorwarth D; Leibfarth S; Pfannenberg C; Reischl G; Mauz PS; Nikolaou K; la Fougère C; Zips D; Welz S
    Acta Oncol; 2017 Nov; 56(11):1577-1582. PubMed ID: 28849721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
    Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
    Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
    Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
    PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
    Tsuchiya H; Matoba M; Nishino Y; Ota K; Doai M; Nagata H; Tuji H
    Radiat Oncol; 2023 Feb; 18(1):24. PubMed ID: 36747228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck.
    Kim SY; Lee SW; Nam SY; Im KC; Kim JS; Oh SJ; Ahn SD; Shin SS; Choi EK; Kim JH
    J Nucl Med; 2007 Mar; 48(3):373-8. PubMed ID: 17332614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous
    Chen J; Hagiwara M; Givi B; Schmidt B; Liu C; Chen Q; Logan J; Mikheev A; Rusinek H; Kim SG
    Sci Rep; 2020 Nov; 10(1):20764. PubMed ID: 33247166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.